Financials
Income statement
Fiscal date | Jun 2025 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | — | — | 13.6B | 13.4B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | 10.2B | 8.4B |
Other operating expenses | — | — | 1.4B | 1.9B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | — | — | -275M | 3.2B |
Tax provision | — | — | 3M | 989M |
Net income | — | — | -279M | 2.2B |
Basic EPS | 13.6 | 9.4 | — | — |
Diluted EPS | 13.6 | 9.4 | — | — |
Basic average shares | 249.9M | 251.2M | — | — |
Diluted average shares | 249.9M | 251.2M | — | — |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |